ABSTRACT
Integration, catalyzed by the viral integrase (IN) protein, is a crucial step in the life cycle of all retroviruses including human immunodeficiency virus type 1 (HIV-1). Although purified HIV-1 IN protein is sufficient to catalyze the DNA breakage and joining steps of integration in the absence of any other protein factor, a number of studies indicate that cellular proteins participate in the integration process in cells. These host cell proteins have been proposed to act through binding the pre-integrated viral cDNA substrate, by directly interacting with the IN protein, and/or by repairing the single-stranded DNA gaps that occur at viral/chromosomal DNA junctions during integration. In this paper we summarize the identification and potential roles of specific cell factors in HIV-1 integration. We also present experimental results of human cell proteins that coimmunoprecipitated with HIV-1 IN following its expression in HeLa cells and discuss these results in light of the previously-identified integration cofactors.
INTRODUCTION
Retroviruses are distinct amongst animal viruses in that they are the only viruses whose replication requires the stable integration of their genetic material into that of the host. This feature is made possible by the viral IN, a specialized DNA recombinase that is packaged into retroviral particles (reviewed in reference 1). Soon after entering a susceptible target cell, uncoated retroviral particles undergo reverse transcription in the context of high molecular weight nucleoprotein complexes known as reverse transcription complexes (2-4; reviewed in reference 5). Reverse transcription generates a linear, doublestranded cDNA containing a copy of the viral long terminal repeat (LTR) at each end. In order for a productive infection to occur, HIV-1 cDNA must become integrated into a host cell chromosome (6-13).
A number of studies have indicated that normal cellular proteins are likely to help the IN accomplish functional HIV-1 cDNA integration in infected cells (reviewed in reference 14). Since many of these proteins were identified using biochemical screens, their physiological relevant role(s) in integration requires confirmation through genetic tests. Here we review the identification and proposed roles of cellular proteins in HIV-1 cDNA integration and discuss experiments that could help clarify the function(s) of these proteins in the context of HIV-1 infection. Although similar reviews have been written (14-16), a number of recent findings including the results of the first cell-based genetic assay to investigate the roles of IN catalytic cofactors (17) and the identification of novel interacting proteins for HIV-1 IN (18, 19) warrant this timely update.
INTEGRATION MECHANISM

Reactions
Linear retroviral cDNA is the substrate for INmediated DNA recombination (20-23). Integration proceeds in three steps: 3' processing, DNA strand transfer, and gap repair (figure 1). 3' Processing and DNA strand transfer are distinct endonucleolytic reactions catalyzed by the IN. In contrast, gap repair is likely catalyzed by host cell enzymes (24, 25; reviewed in references 1 and 14).
IN performs its first endonucleolytic reaction soon after reverse transcription is completed. IN recognizes and acts on short sequences (12 to 20 bp) called attachment (att) sites that are located at the LTR termini (figure 1) (reviewed in reference 26). For HIV-1, a dinucleotide is hydrolyzed from each att site during 3' processing (figure 1A) (27-30). The resulting 3' hydroxyl groups are the nucleophiles that IN then uses to promote DNA strand transfer (29) . The viral cDNA ends are used to cut the target DNA in a staggered fashion, which covalently links the viral 3' ends to the 5' phosphates of the cut (figure 1B). The resulting product is a gapped recombination intermediate with the 5' ends of the virus remaining unattached to the chromosome (21-23). DNA repair is then needed to complete the integration process ( figure 1C ). Since HIV-1 integration yields a 5 bp duplication flanking the integrated provirus (31, 32), HIV-1 IN affects a 5 bp staggered cut in chromosomal DNA during DNA strand transfer.
In addition to the productive integration pathway, some unintegrated cDNA travels down nonproductive pathways that preclude virus infection. Covalently closed DNA circles containing either one or two copies of the LTR, referred to as 1-LTR and 2-LTR circles, respectively, are found in the nuclei of infected cells (20; reviewed in reference 33). Whereas 1-LTR circles are formed in part by the Rad50/Mre11/NBS1 complex implicated in cellular homologous DNA recombination (34), 2-LTR circles are formed by the nonhomologous end joining (NHEJ) pathway of DNA recombination (35) ( figure 1D ). In addition to these host enzyme-mediated products, IN can generate nonproductive DNA circles by a process called autointegration whereby retroviral cDNA prematurely integrates into itself instead of a host chromosome ( figure  1E ). Approximately 20% of Moloney murine leukemia virus (MoMLV) DNA circles were identified as products of autointegration (36), indicating that autointegration may occur at a relatively high frequency in MoMLVinfected cells. Preintegration complexes (PICs) are defined as high molecular weight nucleoprotein complexes isolated from cells that can catalyze the integration of endogenous viral cDNA into an exogenous recombinant target DNA in vitro (20-23, 37, 38). Although MoMLV PICs recovered from cells in isotonic salt-containing lysis buffer catalyzed normal intermolecular integration activity (21, 22, 39), autointegration was induced by treating the PICs with relatively high concentrations of salt and then purifying the complexes on the basis of size (39). This suggested that the high salt treatment removed a protein(s) that normally protected MoMLV from autointegration, and a subsequent study identified the barrier-to-autointegration factor (BAF) as a mouse cell protein that restored normal integration when it was added back to salt-treated MoMLV PICs (40). Autointegrated HIV-1 DNA can be identified in cell extracts (41) and PICs derived from avian cells infected with Rous sarcoma virus supported robust autointegration activity (23, 42), suggesting that autointegration is a normal part of retroviral infection and that all retroviruses have likely evolved a mechanism(s) to suppress this non-productive suicidal infection pathway. 
IN and PICs
Results of numerous structural and functional analyses revealed that retroviral INs are comprised of three protein domains: the N-terminal domain (NTD), catalytic core domain (CCD), and C-terminal domain (CTD) (figure 2) (reviewed in references 43, 44). The NTD (HIV-1 residues 1 to 49) contains two His and two Cys residues that are conserved amongst retroviral and retrotransposon INs (45, 46). These residues coordinate zinc (47, 48) and contribute to functional IN multimerization (49, 50). The CCD (residues 50 to 212) harbors a triad of invariant residues (Asp-64, Asp-116, and Glu-152 for HIV-1) that comprise the enzyme active site (51-56). Other conserved CCD residues make important contacts with viral (57-61) and target (54, 61-63) DNA during integration. The less conserved CTD (HIV-1 residues 213 to 288) forms an SH3-like fold (64, 65) that also contributes to IN multimerization (66, 67) and makes sequence-specific (68) and non-specific (67, 69-71) contacts with DNA (figure 2). Purified retroviral IN is sufficient to catalyze the 3' processing and DNA strand transfer steps of integration in the absence of any other protein component (28-30, 87-91). Early reaction conditions with double-stranded oligonucleotide substrates revealed that in contrast to the concerted integration of both viral DNA ends (figure 1B) that generates the 5 bp sequence duplication in HIVinfected cells, the majority of DNA strand transfer products resulted from the integration of a single viral DNA end into just one strand of target DNA (89). Since HIV-1 PICs preferentially catalyzed concerted integration in vitro (38, 86), a potential role for PIC-associated host factors could be to increase the fidelity of HIV-1 IN's concerted integration activity. However more recent results have demonstrated that purified HIV-1 IN protein is not as inept at catalyzing concerted integration as once thought. Using optimized protein purification and integration reaction conditions, up to 35% of DNA strand transfer products resulted from concerted integration (91). Based on this, it is unclear if HIV-1 would require a host cell factor(s) to enable the high rate of concerted integration that is observed with PICs isolated from cells.
Target site selection
In the absence of any other protein, purified HIV-1 IN displays a slight preference for integration adjacent to purine residues (92). In cells, HIV-1 shows somewhat more target site specificity, as weak 5 bp GTA(A/T)(T/C) (93) and 5' GT(A/T)AC (94) integration consensus sites can be observed. More recent studies that utilized human genomewide mapping approaches demonstrated that HIV-1 shows an approximate twofold preference for integration into genes (95, 96). Although MoMLV did not show a similar strong overall preference for genes, in this case the 5' ends of genes were preferentially targeted over downstream regions (96). These results can be compared and contrasted to the lifestyles of certain yeast retrotransposons. Retrotransposons are similar to retroviruses in that reverse transcription generates a cDNA substrate for IN-catalyzed integration, and subsequent proviral gene expression generates polyproteins that coalesce into viruslike particles. The major distinction between retrotransposons and retroviruses is that the yeast elements lack an extracellular viral phase.
Yeast retrotransposons Ty1 and Ty3 integrate into specific regions upstream of actively transcribed RNA polymerase III genes (reviewed in references 14 and 97). The specificity for Ty3, which is quite exquisite as it occurs within one to two nucleotides of tRNA transcription start sites, is mediated through interactions with the TFIIIB and TFIIIC components of the yeast transcription machinery (reviewed in reference 98). Sitespecific integration would seem to help maintain a gentle balance between intracellular retrotransposition and potentially lethal insertional mutagenesis in yeast. Retroviruses on the other hand need to spread from cell to cell and successfully multiply their overall systemic numbers. It therefore seems plausible that the unique patterns of HIV-1 and MoMLV integration observed in cells impart subtle yet important growth advantages in the face of active immune responses (99) . Regardless of the precise reason, it seems reasonable to propose that HIV-1 and MoMLV interact with specific intracellular component(s) of the host to achieve their unique patterns of in vivo integration. Characterizing the mechanism of retroviral integration site targeting is an ongoing area of active research.
HOST PROTEINS IMPLICATED IN INTEGRATION
Cellular proteins that may function with HIV-1 to accomplish integration in cells can be grouped into two broad classes: those that act during IN catalysis (figure 1A and 1B), and those that act during the subsequent repair steps of DNA recombination ( figure 1C) (107) .
HMGA proteins are low molecular weight nonhistone chromatin-associated proteins that preferentially bind to AT-rich regions located in the minor groove of DNA (108) . The quasi specific nature of this DNA binding is mediated by highly conserved 11-residue domains known as AT-hooks that display affinity for a variety of altered DNA structures such as four-way junctions, supercoiled DNA, and nucleosomes (reviewed in reference 109). AT-hooks, like the intact HMGA1 protein, exhibit very little secondary structure but adopt a crescent shape that fits into the minor groove when DNA is bound (110) . HMGA1 contains three AT-hooks, and these multiple DNA-binding motifs enable HMGA1 to induce local conformational changes in DNA such as bending, looping, unwinding or straightening out of bent regions. HMGA1 is suggested to participate in transcriptional regulation of genes whose promoters contain or are close to AT-rich regions. By binding to DNA and other proteins, HMGA1 is able to promote the formation of enhanceosomes, which in turn activate transcription (111) .
In addition to its identification as a component of HIV-1 (77) and MoMLV (107) PICs, purified HMGA1 protein stimulated the DNA strand transfer activity of purified IN protein in in vitro integration assays (100, 112) . Since HMGA1 does not physically interact with IN (77, 100), it would appear to act through DNA binding and it has been suggested that HMGA1 might bridge the two ends of viral cDNA together within the intasome. Potential binding sites for HMGA1 have been identified in the HIV-1 LTR (77, 113). A related end-bridging function for a host cell protein in integration likely functions in E. coli, where the bacterial Hu protein plays an important architectural role in transpososome formation and transposition (114) . Alternatively, HMGA1 could help PIC-associated cDNA to fold by binding to multiple internal AT-rich regions, yielding an overall nucleoprotein structure proficient for integration (111, 112) . A recent herculean effort in chicken DT40 cell gene disruption yielded cell lines ablated for HMGA1, HMGA2, or both genes (17). These cell lines were tested for their ability to support retroviral integration using pseudotyped HIV-1 particles capable of single infectious cycles as well as replication-competent avian viruses. Somewhat surprisingly, integration of both types of virus appeared to proceed at normal rates with all derivative cell lines, indicating that neither HMGA1 nor HMGA2 plays an obligate role in retroviral cDNA integration under these conditions of virus infection (17).
BAF
BAF was identified through its ability to both suppress the autointegration activity of salt-depleted MoMLV PICs and restore their normal intermolecular integration activity (40). Unlike MoMLV, salt-treated HIV-1 PICs are catalytically inactive (77, 106). Purified BAF protein nonetheless restored intermolecular integration activity to salt-inactivated HIV-1 PICs (106) . This observation enabled side-by-side comparisons of BAF and HMGA1 in functional PIC reconstitution assays.
BAF was significantly more active (about 500 fold) than HMGA1 in both HIV-1 (77, 106) and MoMLV (78, 79, 84) PIC reconstitution assays. Other results from in vitro reconstitution assays also highlighted a role for BAF in PIC structure and function. BAF restored the native intasome structures of salt-treated HIV-1 and MoMLV PICs under conditions wherein HMGA1 failed to function (84, 106). Salt-stripping partially impeded the migration of MoMLV PICs in sucrose gradients, and only BAF restored the normal pattern of MoMLV PIC sedimentation in sucrose (79). Like HMGA1 (77, 107), BAF is a component of MoMLV (79) and HIV-1 (80) PICs. However unlike HMGA1 (107, 112) , BAF failed to detectably stimulate the activity of purified HIV-1 IN in in vitro integration assays (112, 115) .
BAF is an 89 amino acid DNA-binding protein that is highly conserved in multicellular organisms from C. elegans to humans, showing 97% identity between human and murine homologs (116) . This underscores the importance of BAF for cells and indicates that interactions with other proteins may have prevented its evolutionary divergence. Interactions with both DNA and nuclear proteins have been highlighted. BAF forms higher-order nucleoprotein complexes with double-stranded DNA at a ratio of approximately five BAF dimers to five DNA molecules (102) . BAF also interacts with nuclear proteins that harbour a conserved LEM (LAP2 [lamin-associated polypeptide 2], emerin, MAN1) domain, both when DNAbound (117) or free from DNA (118, 119) . These inner nuclear membrane (INM) proteins bridge the INM to the nuclear lamina, providing a physical framework to the nucleus (reviewed in reference 120).
Knockdown of BAF in C. elegans embryos by RNA interference (RNAi) led to early embryonic lethality (under the 100 cell-stage) with almost 100% penetrance. Major defects were observed during mitosis and included abnormal chromosome segregation as well as trailing of chromatin between daughter cells (102) . Interestingly, these anaphase chromatin bridges also resulted from doubleknockdown of emerin and MAN1 in C. elegans, which could reflect the inability to exit mitosis (121) . These results suggested that chromatin/BAF/emerin/MAN1 complexes play a crucial, non-redundant role in postmitotic nuclear reassembly and chromatin decondensation (122) . BAF could provide a physical link between recondensing chromosomes and emerin (123) . Furthermore, since BAF binds to proteins that are part of the nuclear architecture as well as to DNA, it was postulated that BAF plays a role in linking chromatin to the INM, thus contributing to the stability of the interphase nucleus (117) . Besides its hypothesized and extensively studied function in nuclear architecture and dynamics, BAF was recently shown to interact with and inhibit the transactivation function of the paired-like homeodomain transcription factor cone-rod homeobox (Crx) (124) . Inhibition could arise from Crx sequestration in a subcellular compartment such that it fails to gain access to its DNA target, or from inducing conformational changes in BAF-bound Crx thus preventing it from binding to DNA. BAF has also been implicated in human disease, as it is the HB autoantigen associated with rare cases of rheumatoid arthritis and systemic lupus erythematosus (125) .
Solution and X-ray crystallographic structures of BAF reveal a globular protein composed of five alpha helices surrounding a hydrophobic core with four Cys residues involved in hydrogen bonding and core stabilization (116, 126) . BAF is a homodimer in solution with dimerization occurring through evolutionarilyconserved hydrophobic residues and a single salt bridge. BAF possesses a helix-hairpin-helix (HhH) motif between residues 20 and 35 (figure 3) that is frequently found in proteins such as DNA polymerases, ligases, glycosylases and helicases that bind DNA non-specifically (127) . This region contains two anti-parallel alpha helices connected by a conserved GhG (Gly-hydrophobic residue-Gly) motif that adopts a hairpin conformation and interacts with DNA. BAF-DNA interactions (101, 102) are likely mediated via hydrogen bonds between positively charged residues in the HhH domain and phosphate groups on the DNA backbone (126) . DNA binding appears to increase the affinity of BAF for interacting with LEM domain proteins, as residues essential for DNA binding (Lys-6, Gly-25, Gly-27, and Leu-46) were required for wild-type levels of emerin binding as well (122) . The postulated emerin-binding site on BAF, comprised of Val-51, Lys-53, and Lys-54, is distinct from the HhH DNA binding domain (figure 3) (122) . Thus, although DNA and emerin bind to different surfaces of the BAF dimer, DNA binding appears to induce a conformational change such that the affinity of BAF for emerin increases over that of DNA-free BAF (122) .
How might this nuclear architectural factor function during the early phase of retroviral replication? After binding to newly synthesized cDNA and thereby helping to mediate PIC formation, BAF might compact the DNA to limit its availability for autointegration as well as promote association with target DNA when the PIC encounters a chromosome (40, 79, 106 ). Recent results demonstrate that BAF is incorporated into HIV-1 virions at the fairly low stoichiometry of zero to three BAF dimers per virus (103) . Although BAF failed to appreciably interact with HIV-1 IN, BAF bound the matrix (MA) domain of the Gag polyprotein precursor with an apparent affinity constant of 1.4 micromolar. BAF expression was unexpectedly low in purified resting T-cells until the cells were activated to divide (103) . These findings suggest the intriguing model that BAF is incorporated into viral particles through its interaction with Gag/MA to ensure that sufficient quantities of the protein are available for PIC formation during the next round of infection. This scenario could be particularly important in resting human T-cells where the concentration of the factor appears exceptionally low. An important test of this model could include the construction of HIV-1 particles in cells that were depleted for the BAF protein through the use of RNAi, and subsequent infectivity measurements in resting versus activated primary T-cells.
IN binding proteins
Human proteins that directly interact with HIV-1 IN have been detected using yeast two-hybrid screens, coimmunoprecipitation via antibodies directed against recombinant IN protein, and/or in vitro interaction or "pulldown" assays. Of the resulting interacting factors, INI1, LEDGF/p75, EED, and human HSP60 (hHSP60) have been proposed to play catalytic cofactor roles during HIV-1 integration.
INI1
INI1, identified via yeast two-hybrid, was the first host protein discovered to interact with HIV-1 IN (104) . The interaction, which was confirmed by glutathione S-transferase (GST) pull-down, mapped to the NTD of IN (figure 2). Recombinant INI1 protein stimulated the in vitro integration activity of purified IN ten-to twenty-fold, suggesting a catalytic cofactor role for INI1 in HIV-1 integration. INI1 is homologous to the yeast SNF5 protein (104) , an essential component of the SWI/SNF chromatin remodeling complex. SWI/SNF complexes are ATPdependent chromatin remodeling machines (reviewed in reference 128). Upon binding and subsequent ATP hydrolysis, free energy for interconversion between nucleosomal states is generated thus enabling a change of nucleosomal conformation. Interactions between DNA and histones are loosened during a transitional activated state that leads to transcriptional activation or repression of neighboring regions. INI1 has been reported to interact with other viral proteins such as the Epstein-Barr virus nuclear antigen 2 (129) and human papillomavirus E1 (130) as well as cellular factors c-MYC (131), ALL1 (132) , and p53 (133) . INI1 also acts as a tumor suppressor, as mutations in the INI1 gene can lead to atypical teratoid and rhabdoid tumors, suggesting a role for the SWI/SNF complex in control of the cell cycle (134; see reference 135 for a complete review).
INI1 is normally found in the cell nucleus (136) . However, shortly after HIV-1 entry INI1 is exported together with the promyelocytic (PML) protein to the cytoplasm of interphasic cells through the exportinmediated pathway in response to a viral-induced signal (137). Relocalization occurred 30 min to 6 h post-infection during which time colocalization with incoming PICs was observed, which was then followed by INI1 and PML returning to the nucleus. Binding of INI1 to PICs via IN may mediate the subsequent recruitment of SWI/SNF components for what could be an effective way of targeting HIV-1 to SWI/SNF remodeled regions of the genome. In this vein it is noteworthy that SWI/SNF-mediated remodeling is more frequently associated with repression than activation events, at least in yeast (138) . Extending this observation to humans, associated INI1 might preferentially target HIV-1 to repressed genes which is in contrast to the reported preferential integration into active gene regions (95). Alternatively, recruitment of PML to PICs could potentially promote the association of PMLinteracting proteins such as histone acetyltransferase CBP/p300 or transcription factors (139) that could in turn trigger integration into transcribed regions of the genome.
INI1 contains three conserved regions including two direct imperfect repeats, repeat (Rpt) 1 and Rpt2, and a carboxyl-terminal coiled-coiled domain that is also referred to as homology region 3 (HR3) (figure 4) (140) . INI1 harbors a DNA-binding region just upstream of Rpt1 (figure 4) (140) . Overexpression of an internal S6 fragment of INI1, which corresponds to residues 183-294 and 
LEDGF/p75
LEDGF/p75 is a 530 residue DNA-binding protein implicated in cell differentiation and cellular response to environmental stress (reviewed in reference 143). Elevated levels of LEDGF/p75 were observed in mammalian cells following stress such as heat, exposure to toxic agents like ethanol, or oxidizing agents (144) . Upon binding to stress-related elements or heat shock elements in DNA (145, 146) , LEDGF/p75 activates the transcription of stress-related genes thereby triggering a survival response that protects cells from stress-induced damage (143) .
LEDGF/p75 was identified as an IN-interacting protein via over-expressing FLAG-tagged HIV-1 IN in 293T cells and subsequent coimmunoprecipitation with anti-FLAG antibodies (18). When expressed in human cells on its own in the absence of other viral proteins, HIV-1 IN localizes to nuclei and is therefore karyophilic (18, (147) (148) (149) (150) (151) (152) (153) (154) . IN and LEDGF/p75 colocalized in cell nuclei during interphase and were both tightly bound to chromosomes (18, 154) . Selective depletion of LEDGF/p75 via smallinterfering RNA (siRNA) abolished IN nuclear localization, leading instead to a diffuse cytoplasmic pattern (154) . The IN-LEDGF/p75 interaction was confirmed in vitro via a His 6 Tag pull-down assay using His 6 -tagged IN and purified recombinant LEDGF/p75 (154) . Purified LEDGF/p75 additionally stimulated the in vitro integration activity of recombinant HIV-1 IN protein (18). Taken together, these results suggest a role for LEDGF/p75 in HIV-1 nuclear localization, IN catalysis, and perhaps targeting PICs to particular chromosomal regions for integration. Defining the precise role(s) of LEDGF/p75 in integration and HIV-1 replication is an ongoing area of research. Many investigators are likely testing HIV-1 infectivity and integration in cells knockeddown for LEDGF/p75 protein using either the described siRNA (154) or an effective short-hairpin (sh) RNAexpressing retroviral vector (155) . LEDGF/p75 is evolutionarily conserved from Xenopus to humans, and several functional regions can be identified (figure 5). A functional nuclear localization signal (NLS) has been proposed to reside between residues 149 and 156 (143) . Four potential DNA-binding regions, three helix-turn-helix (HTH) motifs and a basic leucine zipper, can also be identified (figure 5) (143) . The Nterminal region of LEDGF/p75 harbors an approximate 80 residue PWWP domain, named for a conserved Pro-TrpTrp-Pro motif (which is Pro-His-Trp-Pro in LEDGF/p75) found in a variety of chromatin-associated proteins (reviewed in reference 156). PWWP has been proposed to function as a DNA-binding (157) and/or protein-protein interaction domain (156) . Delineating the precise role of the PWWP domain in the normal biology of LEDGF/p75 requires further experimentation.
The LEDGF gene also expresses a smaller splice variant that encodes for the 333 residue p52 protein (158) . Interestingly, p52 failed to interact with HIV-1 IN in the in vitro pull-down assay and in live cells (154) . Since the Nterminal 325 residues of LEDGF/p75 and p52 are identical, (154) . When expressed on their own, IN's NTD and CTD fragments displayed even cellular distribution and irregular nuclear accumulation, respectively, and did not co-localize with LEDGF/p75. Despite this finding, the NTD H12N point mutant protein, which displayed reduced affinity for zinc in an in vitro binding assay (159) , failed to interact with LEDGF/p75 in vitro and displayed diffuse fluorescence in cells (154) . Based on this it appears that an intact NTD likely stabilizes the overall IN-LEDGF/p75 interaction. Since mutations in the NTD zinc-binding residues of feline immunodeficiency virus IN also impaired the karyophilic properties of that protein (160), it is tempting to speculate that LEDGF/p75 may be a cellular binding partner for a variety of retroviral INs.
EED
EED (161) is a nuclear protein belonging to the WD-repeat superfamily (162) as well as the Polycomb group (PcG) of proteins (163) . As for many PcG proteins (164), EED is part of a protein complex involved in transcriptional repression and gene silencing promoted by histone deacetylation (165). The most readily discernible structural features of EED are seven WD repeats (figure 6). WD repeats are conserved repeated units typically ending with Trp-Asp residues (162).
Prior to its discovery as an IN-binding protein, EED was identified as a cellular interactor for the HIV-1 MA protein (166) . Bacteriophage panning, GST pulldown, and yeast two-hybrid assays then demonstrated that EED and IN interacted in vitro and in yeast (19). The EED-IN interaction mapped to the CTD of IN (figure 2) and to two distinct regions in the N-terminal half of EED (figure 6) (19). The EED C-terminal region also appears to contribute to the EED-IN interaction, perhaps by stabilizing the complex and/or effecting an overall conformational change that maximizes binding (19).
Purified EED protein stimulated the in vitro integration activity of recombinant HIV-1 IN between twoand thirty-fold (19). Interestingly, EED and IN colocalized within HIV-infected cells. The two proteins were observed together in cell nuclei and near nuclear pores with maximum colocalization occurring at 6 h post-infection (19). Triple colocalization of IN, EED, and MA was also observed in the nucleoplasm at 6 h post-infection, demonstrating the occurrence of these three proteins in what would seem to be the same multi-protein complex under physiologically-relevant conditions (19). EED also interacted with a histone deacetylase in the presence of transcription factor YY1 and the enhancer of Zeste 2 protein (167) . These interactions suggest that YY1 might bridge EED and DNA, leading to silencing of targeted chromatin regions. It was proposed that recruitment of YY1-bound EED could abolish gene silencing, resulting in transcriptionally active regions (19) that could serve as preferential targets for HIV-1 integration (95). Confirmation of a role for EED in targeted HIV-1 integration requires further experimentation. EED was more recently shown to interact with the HIV-1 Nef protein (168) . More experiments are required to address which of 
HSP60
S. cerevisiae heat shock protein 60 (yHSP60) was identified as an interactor of HIV-1 IN via passing yeast cell extracts over an IN-affinity column (105) . Three other yeast proteins, the neoglycogenesis PCK1 enzyme, the tubulin chaperone CCT4, and translation elongation factor (EF)-1-alpha were also identified as IN-binding proteins in this screen. HIV-1 IN also interacted with hHSP60, and the interaction was mapped to the IN CCD (figure 2) (105). Purified recombinant hHSP60 protein stimulated the in vitro 3' processing and DNA strand transfer activities of purified IN protein two-to four-fold (105) . As a chaperone, HSP60 forms a complex with the co-chaperonine HSP10, which is able to bind misfolded proteins and refold them in an ATP-dependent manner (reviewed in reference 169). Since purified HIV-1 IN was a substrate for the HSP60-HSP10 complex, it was postulated that HSP60-HSP10 could activate and/or stabilize IN in HIV-infected cells.
HSP60 also binds hepatitis B virus DNA polymerase (170) , and other chaperones were previously shown to associate with vesicular stomatitis virus (171), vaccinia virus (172), influenza virus (173), and adenovirus (174) . Considering that the level of hHSP60 is elevated in virus-infected cells (175), HSP60 and, more generally, protein chaperones may represent a general cellular stress response to viral infection. Further experimentation is required to establish a physiologically-relevant role for hHSP60 during the early stages of HIV-1 infection.
A survey of human cell proteins that coimmunoprecipitate with HIV-1 IN
Mutations in IN can cause pleiotropic effects on the HIV-1 life cycle, which in addition to integration can impair virus assembly/release and/or reverse transcription (reviewed in reference 176). This observation suggests that IN may interact with a variety of host cell proteins during HIV-1 infection. To establish a comprehensive picture of human cell proteins that bind HIV-1 IN, we conducted the following large-scale coimmunoprecipitation experiment. Codon-optimized FLAG-tagged HIV-1 IN was expressed from the murine retroviral MSCVpuro vector (Clontech) as previously described (153) . As controls we utilized the empty vector as well as one engineered to express the V165A mutant IN protein. Viruses containing the V165A change are defective in reverse transcription (R. Lu & A. Engelman, unpublished observations), integration (152) , and possibly at a post-nuclear entry step (177) . The V165A change was incorporated into the IN reading frame as previously described (153) .
Suspension-adapted HeLa cells were transduced with the viral vectors, and extracts from approximately 6 L of cells were prepared by lysis in buffer containing 50 mM Tris pH 8.0, 500 mM KCl, 0.1% Triton X-100, 2.5% glycerol, and Complete Protease Inhibitor cocktail (Roche). IN-associated proteins were immunoprecipitated with anti-FLAG M2 affinity matrix (Sigma) and eluted with the FLAG peptide (Sigma). Eluted proteins were resolved by 4-20% Tris-Glycine SDS-PAGE (Novex) and stained with Simply BlueSafeStain (Invitrogen) (figure 7). Gel-resolved proteins were digested with trypsin, the mixtures fractionated on a Poros 50 R2 RP micro-tip, and the resulting peptide pools were analyzed by matrix-assisted laser-desorption / ionization reflectron time-of-flight (MALDI-reTOF) mass spectroscopy (MS) using a BRUKER UltraFlex TOF/TOF instrument (Bruker Daltonics) as previously described (178, 179) . Selected experimental masses were taken to search a non-redundant protein database ('NR'; ~1.4 x 10 6 entries; National Center for Biotechnology Information) utilizing the PeptideSearch (Matthias Mann, Southern Denmark University) algorithm, with a mass accuracy restriction better than 40 ppm and maximum one missed cleavage site allowed per peptide. Mass spectrometric sequencing of selected peptides was done by MALDI-TOF/TOF (MS/MS) analysis on the same prepared samples using the UltraFlex instrument in 'LIFT' mode. Fragment ion spectra were taken to search NR using the MASCOT MS/MS Ion Search program (Matrix Science Ltd.). Identifications thus obtained were verified by comparing the computer generated fragment ion series of the predicted tryptic peptide with the experimental MS/MS data.
With one exception, every protein coimmunoprecipitating with the wild-type IN also purified with the V165A mutant (figure 7). Given their relative intracellular abundance, the significance of the beta-actin, beta-tubulin, EF-1-alpha, and HSP73 interactions is unknown. Indeed, several of these proteins were previously shown to interact with other HIV-1 proteins. Beta-actin interacts with HIV-1 nucleocapsid (180, 181) , Nef (182) , and reverse transcriptase (183) . EF-1-alpha interacts with the Gag polyprotein (184) and as discussed in the previous section the yeast homolog of EF-1-alpha was previously identified as an IN-binding protein (105) . Furthermore, both EF-1-alpha and beta-actin are incorporated into HIV-1 virions (185, 186) . With regard to beta-tubulin, a peptidebased yeast 2-hybrid screen identified microtubuleassociated proteins as interactors of HIV-1 IN (187) . Given the relative strength of the interaction between beta-tubulin and defective V165A IN (figure 7), the physiological relevance of interactions between HIV-1 IN and tubulin/microtubules is unclear and requires further experimentation. (154) previously reported that the H12N change in the NTD significantly reduced the binding of LEDGF/p75 to IN, ours is the first description of a CCD change that appears to significantly reduce the affinity of LEDGF/p75 for IN. A relatively low level of the serine-threonine kinase nuclear Dbf2-related (NDR) (see reference 188 for review) was also identified in this screen (figure 7). Although NDR appeared to specifically interact with both wild-type and V165A IN, subsequent experiments revealed low levels of NDR binding to the anti-FLAG M2 affinity matrix in the absence of IN expression (data not shown). Because of this, it is currently unclear if NDR is a specific interactor of HIV-1 IN.
Factors implicated in gap repair
The final step of the integration process is gap repair, wherein the DNA recombination intermediate formed by IN's DNA strand transfer activity is converted into the final integrated product (figure 1C). One can envision three different enzymatic activities required for this type of DNA repair: (i) a DNA polymerase to fill-in the single-strand gaps (which are 5 bases for HIV-1), (ii) a flap endonuclease to remove the non-templated dinucleotides from the 5' ends of the virus, and (iii) a DNA ligase to seal the single-strand nicks (figure 1C) (see reference 14 for further details). Experiments with oligonucleotide substrates that mimicked one side of the gapped HIV-1 structure demonstrated that a variety of DNA polymerases including polymerase beta, delta, or HIV-1 reverse transcriptase could fulfill the requirements of step (i), that flap endonuclease I effectively removed the non-templated 5' dinucleotide, and that different DNA ligases including ligase I, III, or IV could seal the nick (25, 189). Since several different polymerases and ligases functioned in vitro, it seems likely that different sets of repair enzymes operate in cells.
DNA repair enzymes and gap repair
Although the results of these in vitro assays identified proteins that fulfilled the roles of DNA repair, the identities of the proteins that carry out the repair process in HIV-infected cells remain unknown. However, cell-based genetic assays have implicated a variety of human proteins that may work via sensing the single-stranded breaks in the recombination intermediate as playing a role(s) in gap repair. Another potential gap repair protein, hRad18, interacts directly with HIV-1 IN (190) .
DNA-PK and NHEJ
NHEJ is the main mechanism of double-stranded DNA break repair in mammalian cells. One of its key components is the DNA-dependent protein kinase (DNA-PK). DNA-PK is a multi-protein complex comprised of a large DNA-PK CS catalytic subunit and the Ku70/Ku86 heterodimer that recognizes and binds double-stranded DNA ends. The other major proteins in NHEJ are XRCC4, DNA ligase IV, and Artemis (reviewed in reference 191).
A mutation in DNA-PK CS that effectively disrupts NHEJ is responsible for the severe combined immunodeficiency (scid) phenotype in mice. (192) . Although a separate study confirmed scid mouse embryo fibroblasts (MEFs) and Kudeficient cells underwent apoptosis as a result of infection, the requirement for a relatively high (>1) multiplicity of infection (moi) prompted the model that DNA-PK played a protective role against cellular toxicity induced by high moi as compared to a direct role in repairing the integration intermediate (193) . A more recent study highlighted a limited connection between retroviral infection and apoptosis of NHEJ-defective cells (34). A survey of seven different cell lines deficient for DNA-PK, Ku80, or DNA ligase IV revealed that only Nalm-6 ligase IV mutant cells underwent apoptosis as a result of high moi infection and that these surviving cells contained proviruses at a level that was indistinguishable from control infections, indicating that a signal other than integration induced toxicity under these conditions. Consistent with this interpretation, Li et al. (35) previously noted that a catalytically-inactive IN mutant virus induced efficient apoptosis of Nalm-6 cells, leading to the model that preintegrated linear viral cDNA supplied the apoptotic signal.
Due to the plethora of conflicting data on a connection between infection, integration, and apoptosis of NHEJdeficient cells, it remains unclear if DNA-PK plays an active role in repairing the integration intermediate or if DNA-PK plays a protective role for the cell during the early stages of retroviral replication. Daniel et al. (24) highlighted that residual integration occurred in NHEJ-deficient cells, raising the notion of an alternative post-integration repair pathway. DNA-PK CS is a phosphatidylinositol-3 kinase related kinase, and other members of this family include the ataxiatelangiectasia mutated (ATM) and ATM-and Rad3-related (ATR) kinases (191). Wortmannin, a sterol-like fungal metabolite, sensitized normal mouse pre-B cells to apoptosis following high moi infection (194) . ATMdeficient cells were particularly sensitive to the effects of wortmannin, leading to the suggestion that ATM activity was required for the residual levels of retroviral transduction observed in NHEJ-deficient cells (194) . A follow-up study revealed that caffeine, which is an efficient inhibitor of DNA repair that likely acts through the ATM and ATR kinases, inhibited retroviral infection at sub-toxic concentrations (195) . Since caffeine-treated cells supported near-normal levels of reverse transcription and 2-LTR circle formation but significantly less provirus formation, caffeine appeared to specifically inhibit integration. Although caffeine reduced infection of ATM-knockout cells, this effect was similar to reductions observed with ATM-expressing cells. In contrast, stable integration was significantly reduced in cells expressing a dominantnegative form of the ATR kinase. Based on this, Daniel et al. (195) proposed an important role for ATR kinase activity in integration gap repair. A potential limitation of these lines of experimentation is unanticipated pleiotropic effects of drugs like wortmannin and caffeine. Overexpressing dominant-negative mutants might also result in the perturbation of off-target cellular proteins/pathways (195) .
PARP-1
Poly(ADP-ribose) polymerase 1 (PARP-1) is another protein-modifying enzyme implicated in DNA repair (see reference 196 for review). After binding to a DNA break, PARP-1 uses NAD+ to catalyze the attachment of poly(ADP-ribose) to a variety of chromatinassociated proteins, including itself. It then dissociates from the DNA, allowing access by other repair enzymes. Experimental approaches to the role of PARP-1 in retroviral integration have included the use of specific inhibitors of enzyme activity, antisense oligonucleotides that reduced enzyme concentration, and knockout mice ablated for both alleles of the PARP-1 gene.
An initial study using three different competitive inhibitors including 3-methoxybenzamide (3-MB) noted two-to five-fold less stable transduction in the presence of drugs (197) . Since an anti-PARP-1 antisense oligonucleotide resulted in parallel reductions of PARP-1 activity and stable transduction, it seemed that PARP-1 played a rate-limiting role in infection, which led to the suggestion that PARP-1 played an important role in gap repair (197) . A subsequent study revealed that the infectivity of an HIV-1 vector was significantly impaired (approximately 23 fold) on MEFs derived from PARP-1-knockout mice as compared to matched PARP-1-expressing cells (198) . However, not all investigators have observed infectivity defects in the absence of PARP-1 activity. Baekelandt et al. (193) observed that hamster cells infected in the presence of relatively high concentrations of 3-MB supported normal levels of virus transduction, discounting an essential role for PARP-1 in HIV-1 integration. Although Siva and Bushman (199) noted that the Ha et al. (198) vector infected PARP-1 -/-MEFs two-to threefold less efficiently than control cells, knockout and control MEFs were infected equally by a separate HIV-1 vector (199) . Based on these contradictory reports, one must posit that PARP-1 does not play an essential role in HIV-1 integration.
IN binding proteins 4.2.2.1. hRad18
The Rad18 protein is involved in the DNA postreplication repair/translesion pathway (reviewed in reference 200). Through binding to single-stranded breaks in DNA, Rad18 is thought to recruit Rad6, an E2 ubiquitinconjugating enzyme (201) to the sites of DNA damage (202) . The stable Rad6-Rad18 heterodimer (203, 204) has been hypothesized to destabilize the polymerase machinery, perhaps via ubiquitination of the stalled DNA polymerase complex, thus bypassing the lesion and allowing time for repair. Human Rad18 (hRad18) was identified as an INinteracting protein by coimmunoprecipitation of HIV-1 IN with FLAG-tagged hRad18 and colocalization of IN with hRad18 in cell nuclei (190) . HIV-1 IN is relatively unstable when expressed on its own in mammalian cells, and stability can be increased via optimizing overall codon usage (205) or the identity of the N-terminal amino acid residue (206) . This latter observation indicated that IN stability is dictated by the N-end rule. Cotransfection of hRad18 with either N-terminal Phe-IN or Arg-IN, which were both unstable (206) , led to increased intracellular IN, suggesting that hRad18 might stabilize IN in vivo (190) (210) . Since MuA possesses overlapping binding sites for the phage-encoded MuB transposition activator and ClpX, release of MuB likely provides timed access to ClpX and thus a mechanism to regulate transpososome dissociation after DNA strand transfer (211) . Such active transpososome disassembly plays an important role in the transition from integration to subsequent Mu DNA repair/replication (212, 213) . Similarly, hRad18 might interact with HIV-1 IN soon after DNA strand transfer. The subsequently formed Rad6-Rad18 heterodimer could then destabilize PIC proteins that may remain tightly bound to the integration intermediate, allowing cellular DNA repair proteins to gain access to the gapped DNA (190) .
SUMMARY AND PERSPECTIVE
This review detailed the potential roles of human cellular proteins in the catalytic and DNA repair steps of HIV-1 integration. Whereas HMGA1, BAF, INI1, LEDGF/p75, EED, and HSP60 have each been implicated as a potential catalytic cofactor for the IN (section 4.1), a variety of other proteins have been implicated as playing roles during the repair of the HIV-1 DNA recombination intermediate (section 4.2). However, solid genetic evidence for the obligate role of any of theses proteins in HIVinfected cells remains scant. Of all the potential catalytic cofactors, only HMGA1 has been studied via a genetic approach, in this case with knockout cell lines (17). Under these conditions neither HMGA1 nor the related HMGA2 protein played a discernable role in integration. With the relatively recent advent of siRNA technology (see reference 214 for review), it should be possible to selectively reduce the concentration of any one of these potential cofactors in cells and assay for resulting effect(s) on HIV-1 integration/infectivity. Indeed, the description of an effective synthetic siRNA (154) and shRNA-expression vector (155) that target human LEDGF/p75 suggests that such experiments are underway for at least a subset of the potential IN catalytic cofactors.
Many of the protein-modifying enzymes implicated in gap repair, in contrast, were identified through the use of cell-based genetic assays. However some of these results are controversial, as they have proven difficult to reproduce (see section 4.2.1). This suggests that certain experimental conditions like the identities of specific viral strains/vectors and/or cell types may have contributed to the results and if this is indeed the case, the roles of these repair-type proteins are likely not essential under all conditions of HIV-1 infection.
We have detailed five different human proteins that interact directly with HIV-1 IN, four of which could act as an IN catalytic cofactor and one as a gap repair factor (table 1) . At least three other human proteins, karyopherinalpha (215), importin 7 (216) and uracil deglycosylase 2 (UNG2) (217) have also been shown to interact with HIV-1 IN. Since karyopherin-alpha and importin 7 were implicated as playing roles in the translocation of HIV-1 PICs across intact nuclear pores and UNG2 was implicated in base excision repair of uracil-containing HIV-1 DNA, we considered these functions as outside the realm of the catalytic steps of DNA recombination and thus did not discuss these IN-interacting proteins in detail.
Finally, we identified HeLa cell proteins that coimmunoprecipitated with HIV- 1 IN (figure 7) . Our results highlighted the interaction between IN and LEDGF/p75, which corroborates recent findings from Debyser and colleagues (18, 154). Although we failed to detect any of the other previously-identified IN-interacting proteins outside of EF-1-alpha in this screen, this should not be taken as evidence for the lack of cofactor specificity.
For example, it is plausible that other IN-interacting proteins were simply not extracted from HeLa cells under conditions where both LEDGF/p75 and IN were efficiently recovered. Ongoing experiments in ours and others laboratories should help determine if LEDGF/p75 or any of the other human proteins discussed in detail in this review play an important role in allowing HIV-1 to accomplish its functional integration in human cells.
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